Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market

Summit Therapeutics (SMMT) Cash flow

Compare
1,304 Followers

Summit Therapeutics Cash Flow

SMMT's free cash flow for Q4 2024 was $-48.69M. For the 2024 fiscal year, SMMT's free cash flow was decreased by $-65.36M and operating cash flow was $-48.67M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -142.11M$ -76.76M$ -41.58M$ -72.59M$ -48.11M
Investing Cash Flow
$ -205.34M$ -587.77M$ -624.00K$ -306.00K$ -421.00K
Financing Cash Flow
$ 381.23M$ 86.51M$ 620.24M$ 77.92M$ 50.55M
End Cash Position
$ 105.19M$ 71.42M$ 648.61M$ 71.79M$ 66.42M
Free Cash Flow
$ -142.25M$ -76.89M$ -42.21M$ -72.89M$ -48.53M
Currency in USD

Summit Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis